Vaccine effectiveness of 99.3% seen in fully vaccinated: Mandaviya

Vaccine effectiveness of 99.3% has been seen in individuals fully inoculated against Covid as per the data uploaded on India Covid-19 Tracker till January 2, the Parliament was told on Friday

coronavirus, covid-19, vaccine, vaccination, teenager, children
IANS New Delhi
2 min read Last Updated : Feb 05 2022 | 8:24 AM IST

Vaccine effectiveness of 99.3 per cent has been seen in individuals fully inoculated against Covid as per the data uploaded on India Covid-19 Tracker till January 2, the Parliament was told on Friday.

The Indian Council of Medical Research (ICMR) has developed the India Covid-19 Vaccine Tracker, by merging mainly three national databases -- CoWIN, National Covid-19 Testing database and Covid-19 India portal, Health Minister Mansukh Mandaviya told the Lok Sabha in a written reply.

"The latest data analysed and uploaded till January 2, 2022 depicts vaccine effectiveness of 99.3 per cent in fully vaccinated individuals against Covid-19," he said, adding that the tracker is updated periodically and displays the effectiveness of partial and full vaccination against Covid-19.

He said that the Omicron variant is the dominant variant in the country presently. Whole genome sequencing for Omicron variant is done for all RTPCR positive samples from international travellers arriving since November 28, 2021.

Stressing that the Centre is supporting states in their endeavour to manage Covid-19 since the beginning of the pandemic, Mandaviya said that given the emergence of mutated variants with variable impact on transmissibility, virulence and effectiveness of vaccines, the likelihood of resurgence of Covid-19 trajectory in the country is monitored by various expert committees under ICMR, DGHS and other departments.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Coronavirus Vaccine

First Published: Feb 05 2022 | 7:58 AM IST

Next Story